Your browser doesn't support javascript.
loading
Checkpoint Immunotherapy-Induced Myocarditis and Encephalitis Complicated With Complete AV Block: Not All Hope Is Lost.
Lorente-Ros, Álvaro; Rajjoub-Al-Mahdi, Ez-Alddin; Monteagudo Ruiz, Juan M; Rivas García, Sonia; Ortega Pérez, Rodrigo; Fernández Golfín, Covadonga; Álvarez-García, Jesús; Zamorano Gómez, José L.
Affiliation
  • Lorente-Ros Á; Cardiology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain.
  • Rajjoub-Al-Mahdi EA; Centro de Investigación Biomédica en Red, CIBER Cardiovascular, Madrid, Spain.
  • Monteagudo Ruiz JM; Cardiology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain.
  • Rivas García S; Cardiology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain.
  • Ortega Pérez R; Cardiology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain.
  • Fernández Golfín C; Cardiology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain.
  • Álvarez-García J; Cardiology Department, Hospital Universitario Ramon y Cajal, Madrid, Spain.
  • Zamorano Gómez JL; Centro de Investigación Biomédica en Red, CIBER Cardiovascular, Madrid, Spain.
JACC Case Rep ; 4(16): 1032-1036, 2022 Aug 17.
Article in En | MEDLINE | ID: mdl-36062054
ABSTRACT
Immune checkpoint inhibitors are associated with a myriad of autoimmune adverse events. We present a 70-year-old patient with renal-cell carcinoma treated with nivolumab/ipilimumab complicated with myocarditis and encephalitis in which gradual impairment of the His-Purkinje system progressed to complete atrioventricular block. Full recovery was achieved after treatment with corticosteroids and immunoglobulins. (Level of Difficulty Intermediate.).
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JACC Case Rep Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JACC Case Rep Year: 2022 Document type: Article